Observational studyPediatric nephrology (Berlin, Germany)2025

Variable treatment response to lumasiran in pediatric patients with primary hyperoxaluria type 1.

Sina Saffe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.